These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7433230)

  • 1. Precancerous mastopathie: structural and biological considerations.
    Black MM; Kwon S
    Pathol Res Pract; 1980; 166(4):491-514. PubMed ID: 7433230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural, antigenic, and biological characteristics of precancerous mastopathy.
    Black MM
    Cancer Res; 1976 Jul; 36(7 PT 2):2596-604. PubMed ID: 776395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions.
    Wellings SR; Jensen HM; Marcum RG
    J Natl Cancer Inst; 1975 Aug; 55(2):231-73. PubMed ID: 169369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Definition of precancerous and high-risk mammary lesions.
    Bégin LR
    Can J Surg; 1985 May; 28(3):248-51. PubMed ID: 2986807
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material.
    Xu R; Perle MA; Inghirami G; Chan W; Delgado Y; Feiner H
    Mod Pathol; 2002 Feb; 15(2):116-24. PubMed ID: 11850540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathologic characteristics of carcinomas that develop after a biopsy containing columnar cell lesions: evidence against a precursor role.
    Boulos FI; Dupont WD; Schuyler PA; Sanders ME; Page DL; Fedda FA; Simpson JF
    Cancer; 2012 May; 118(9):2372-7. PubMed ID: 21918964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotaxic fine needle aspiration cytology of clinically occult malignant and premalignant breast lesions.
    Bibbo M; Scheiber M; Cajulis R; Keebler CM; Wied GL; Dowlatshahi K
    Acta Cytol; 1988; 32(2):193-201. PubMed ID: 2831687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear cytometric changes in breast carcinogenesis.
    Mommers EC; Poulin N; Sangulin J; Meijer CJ; Baak JP; van Diest PJ
    J Pathol; 2001 Jan; 193(1):33-9. PubMed ID: 11169513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma.
    Khalifeh IM; Albarracin C; Diaz LK; Symmans FW; Edgerton ME; Hwang RF; Sneige N
    Am J Surg Pathol; 2008 Apr; 32(4):544-52. PubMed ID: 18300793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pathology of premalignant and malignant diseases of the female breast].
    Prechtel K
    Langenbecks Arch Chir Suppl II Verh Dtsch Ges Chir; 1989; ():897-900. PubMed ID: 2577661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathology and heredity of breast cancer in younger women.
    Marcus JN; Watson P; Page DL; Lynch HT
    J Natl Cancer Inst Monogr; 1994; (16):23-34. PubMed ID: 7999466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for breast carcinoma in situ versus invasive breast cancer in a prospective study of pre- and post-menopausal women.
    Reinier KS; Vacek PM; Geller BM
    Breast Cancer Res Treat; 2007 Jul; 103(3):343-8. PubMed ID: 17063272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The integration of diagnostic tests and the role of outpatient surgery in the management of breast disease.
    Ranieri E; D'Andrea MR; D'Alessio A; Bergomi S; Virno F
    Int Surg; 1995; 80(2):181-4. PubMed ID: 8530240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Histologic classification of breast cancer and its precancerous stages].
    Nizze H
    Zentralbl Gynakol; 1987; 109(1):3-14. PubMed ID: 3033949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma in situ of the female breast. A clinico-pathological, immunohistological, and DNA ploidy study.
    Ottesen GL
    APMIS Suppl; 2003; (108):1-67. PubMed ID: 12874968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chromosomal alterations in pure nonneoplastic breast lesions: implications for breast cancer progression.
    Ellsworth RE; Ellsworth DL; Weyandt JD; Fantacone-Campbell JL; Deyarmin B; Hooke JA; Shriver CD
    Ann Surg Oncol; 2010 Jun; 17(6):1688-94. PubMed ID: 20107913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast cancer precursors revisited: molecular features and progression pathways.
    Lopez-Garcia MA; Geyer FC; Lacroix-Triki M; Marchió C; Reis-Filho JS
    Histopathology; 2010 Aug; 57(2):171-92. PubMed ID: 20500230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers.
    Adem C; Reynolds C; Soderberg CL; Slezak JM; McDonnell SK; Sebo TJ; Schaid DJ; Myers JL; Sellers TA; Hartmann LC; Jenkins RB
    Cancer; 2003 Jan; 97(1):1-11. PubMed ID: 12491499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Classification of preinvasive breast and carcinoma in situ: doubts, controversies, and proposal for new categorizations].
    Dauplat MM; Penault-Llorca F
    Bull Cancer; 2004 Dec; 91 Suppl 4():S205-10. PubMed ID: 15899609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.